Clinical Development Stocks List

Clinical Development Stocks Recent News

Date Stock Title
Nov 21 LDOS 3 Aerospace-Defense Stocks to Buy Amid Persistent Supply-Chain Issues
Nov 21 LDOS 5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return
Nov 21 BLRX BioLineRx inks licensing deal, share purchase agreement
Nov 21 QURE uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
Nov 21 BLRX BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
Nov 20 CYTK Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
Nov 20 BLRX BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
Nov 20 LDOS Resource Wars: China and America Battle for Antimony as Prices Surge 200%
Nov 19 LDOS Is Leidos (LDOS) Stock Undervalued Right Now?
Nov 19 CYTK Cytokinetics and Bayer partner to develop for aficamten in Japan
Nov 19 LDOS Leidos Signs Agreement to Enhance AI Innovation in UK: Time to Buy the Stock?
Nov 19 CYTK Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
Nov 19 CYTK Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
Nov 19 CYTK Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
Nov 19 CYTK Bayer acquires rights to Cytokinetics' heart drug in Japan
Nov 19 CYTK Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Nov 18 LDOS Spotting Winners: Axon (NASDAQ:AXON) And Aerospace and Defense Stocks In Q3
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags